Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

FMS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

FMS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Fresenius Medical Care AG American Depositary Receipt(FMS US)

$21.60-0.622.79%Ext:$22.08+0.482.22%(Pre-Market · 14:23:19 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Fresenius Medical Care AG American Depositary Receipt(FMS US)

$21.60-0.622.79%Ext:$22.08+0.482.22%(Pre-Market · 14:23:19 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials

Income Statement

Balance SheetCash Flow
Millions EUR (ex. Per Share)
FY199712/31/1997
FY199812/31/1998
FY199912/31/1999
FY200012/31/2000
FY200112/31/2001
FY200212/31/2002
FY200312/31/2003
FY200412/31/2004
FY200512/31/2005
FY200612/31/2006
FY200712/31/2007
FY200812/31/2008
FY200912/31/2009
FY201012/31/2010
FY201112/31/2011
FY201212/31/2012
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Revenue19,453.619,335.919,627.619,358.3
-Cost of Revenue14,528.614,579.314,598.714,333.9
Gross Profit4,925.04,756.75,028.95,024.4
-Operating Expenses3,555.63,289.33,202.13,203.8
+Selling, General & Admin3,196.33,142.83,032.73,031.0
+General And Administrative Expenses2,489.92,482.42,414.62,455.8
+Selling And Marketing Expenses706.4660.4618.1575.2
+Research and Development232.0183.5158.0152.8
+Other Operating Expenses127.3-37.011.420.0
Operating Income1,369.41,467.41,826.81,820.7
+Non Operating Income-672.8-745.9-629.4-664.3
+Interest Income, Net-336.4-335.5-314.8-312.7
+Interest Income88.271.669.669.3
-Interest Expense424.6407.0384.4382.0
+Other Non-Op Income-336.4-410.5-314.6-351.6
Pretax Income1,033.01,056.91,512.21,469.1
-Income Tax Expense300.6316.1321.0302.7
Income from Cont Ops732.5740.91,191.31,166.4
-Net Extraordinary Losses----
+Discounted operations----
+XO & Accounting Changes----
Income Incl. MI732.5740.91,191.31,166.4
-Minority Interests233.5203.0212.9221.7
Net Income, GAAP499.0537.9978.4944.7
-Prfrrd Div & Other----
Net Income Avail To Common499.0537.9978.4944.7
Weighted Average Shs Out587,056,000587,884,000582,381,1822,293,805,934
EPS0.90.91.71.7
Weighted Average Shs Out Dil586,826,898586,826,898582,381,1502,293,757,074
EPS Diluted0.90.91.71.7

Financials

Income Statement

Balance SheetCash Flow
Millions EUR (ex. Per Share)
FY199712/31/1997
FY199812/31/1998
FY199912/31/1999
FY200012/31/2000
FY200112/31/2001
FY200212/31/2002
FY200312/31/2003
FY200412/31/2004
FY200512/31/2005
FY200612/31/2006
FY200712/31/2007
FY200812/31/2008
FY200912/31/2009
FY201012/31/2010
FY201112/31/2011
FY201212/31/2012
FY201312/31/2013
FY201412/31/2014
FY201512/31/2015
FY201612/31/2016
FY201712/31/2017
FY201812/31/2018
FY201912/31/2019
FY202012/31/2020
FY202112/31/2021
FY202212/31/2022
FY202312/31/2023
FY202412/31/2024
FY202512/31/2025
Last 12M03/31/2026
Revenue19,453.619,335.919,627.619,358.3
-Cost of Revenue14,528.614,579.314,598.714,333.9
Gross Profit4,925.04,756.75,028.95,024.4
-Operating Expenses3,555.63,289.33,202.13,203.8
+Selling, General & Admin3,196.33,142.83,032.73,031.0
+General And Administrative Expenses2,489.92,482.42,414.62,455.8
+Selling And Marketing Expenses706.4660.4618.1575.2
+Research and Development232.0183.5158.0152.8
+Other Operating Expenses127.3-37.011.420.0
Operating Income1,369.41,467.41,826.81,820.7
+Non Operating Income-672.8-745.9-629.4-664.3
+Interest Income, Net-336.4-335.5-314.8-312.7
+Interest Income88.271.669.669.3
-Interest Expense424.6407.0384.4382.0
+Other Non-Op Income-336.4-410.5-314.6-351.6
Pretax Income1,033.01,056.91,512.21,469.1
-Income Tax Expense300.6316.1321.0302.7
Income from Cont Ops732.5740.91,191.31,166.4
-Net Extraordinary Losses----
+Discounted operations----
+XO & Accounting Changes----
Income Incl. MI732.5740.91,191.31,166.4
-Minority Interests233.5203.0212.9221.7
Net Income, GAAP499.0537.9978.4944.7
-Prfrrd Div & Other----
Net Income Avail To Common499.0537.9978.4944.7
Weighted Average Shs Out587,056,000587,884,000582,381,1822,293,805,934
EPS0.90.91.71.7
Weighted Average Shs Out Dil586,826,898586,826,898582,381,1502,293,757,074
EPS Diluted0.90.91.71.7